Fluoroquinolone resistance mechanism of clinical isolates and selected mutants of Pasteurella multocida from bovine respiratory disease in China.
Fluoroquinolone resistance mechanism of clinical isolates and selected mutants of Pasteurella multocida from bovine respiratory disease in China.
复制标题
我国牛呼吸道疾病多杀性巴氏杆菌临床分离株及突变株对氟喹诺酮类药物的耐药机制
DOI:
10.1292/jvms.14-0240
复制
发表时间:
2014-12
期刊:
影响因子:
--
通讯作者:
Ma HX
中科院分区:
文献类型:
--
作者:
Kong LC;Gao D;Gao YH;Liu SM;Ma HX
The minimum inhibitory concentrations (MICs), mutation prevention concentrations (MPCs) and contribution of quinolone resistance-determining region (QRDR) mutations to fluoroquinolone (ciprofloxacin, enrofloxacin and orbifloxacin) susceptibility in 23 Pasteurella multocida (Pm) isolates were investigated. Fluoroquinolone-susceptible isolates (MICs ≤0.25 µg/ml, 9 isolates) had no QRDR mutations, and their respective MPCs were low. Fluoroquinolone-intermediate isolates (MICs=0.5 µg/ml, 14 isolates) had QRDR mutations (Asp87 to Asn or Ala84 to Pro in gyrA), and their respective MPCs were high (4–32 µg/ml). First-step mutants (n=5) and laboratory-derived highly resistant fluoroquinolone mutants (n=5) also had QRDR mutations. The MICs of fluoroquinolones for mutant-derived strains were decreased in the presence of efflux inhibitors. The results indicated that the fluoroquinolone resistance of Pm is mainly due to multiple target gene mutations in gyrA and parC and the overexpression of efflux pump genes.
登录
查看更多内容
影响因子:
5.2
作者:
Michael, Geovana Brenner;Kadlec, Kristina;Schwarz, Stefan
通讯作者:
Schwarz, Stefan
DOI:
10.1016/s0732-8893(01)00335-2
发表时间:
2002-02-01
影响因子:
2.9
作者:
Ribera, A;Jurado, A;Vila, J
通讯作者:
Vila, J
影响因子:
3.3
作者:
Katsuda, K.;Hoshinoo, K.;Mikami, O.
通讯作者:
Mikami, O.
影响因子:
2.8
作者:
Chen, Yen-Ping;Tsao, Ming-Yang;Tsai, Hsiang-Jung
通讯作者:
Tsai, Hsiang-Jung
影响因子:
9.4
作者:
Townsend, KM;Frost, AJ;Dawkins, HJS
通讯作者:
Dawkins, HJS